Internal Medicine, Endocrinology, Diabetes, & Metabolism · Fayetteville, GA
NPI
1710043492
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1265 Highway 54 W Ste 302
Fayetteville, GA, 30214
Phone (770) 506-1590
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
4,057 services
Medicare patients, 2024
264
Average age 74
Drug cost, 2024
$2.3M
4,643 prescriptions
Company payments, 2025
$951
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kelly N Wood was code 99214 (office e&m - established), 307 times for 222 patients. In total Kelly N Wood billed 4,057 services in 16 codes, and Medicare paid $43K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-05-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 307 | 222 | $87.99 | $27K |
| 36415 Venipuncture Blood Collection | Office | 238 | 186 | $8.62 | $2,052 |
| 83036 Blood Count | Office | 128 | 97 | $9.45 | $1,210 |
| 82962 Clinical Chemistry | Office | 119 | 87 | $3.19 | $379 |
| 95251 Test - Miscellaneous | Office | 81 | 49 | $25.33 | $2,052 |
| 99215 Office E&M - Established | Office | 33 | 24 | $128.76 | $4,249 |
| 99204 Office E&M - New | Office | 30 | 30 | $87.23 | $2,617 |
| 99442 Telephone Services | Office | 27 | 24 | $66.63 | $1,799 |
By year: 2022 $61K for 1,196 services; 2023 $64K for 2,372 services; 2024 $43K for 4,057 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 238 | 186 | $8.62 | $2,052 |
| 83036 Blood Count | 128 | 97 | $9.45 | $1,210 |
| 82962 Clinical Chemistry | 119 | 87 | $3.19 | $379 |
Medicare prescription drug claims, 2024
In 2024, the drug Kelly N Wood prescribed most often to Medicare patients was Levothyroxine Sodium, with 497 prescriptions and refills. In total Kelly N Wood wrote 4,643 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 497 | 1,268 | 140 | $4,792 |
| Ozempic Semaglutide | 388 | 708 | 110 | $674K |
| Metformin Hcl Generic | 300 | 824 | 99 | $5,077 |
| Metformin Hcl Er Metformin Hcl | 251 | 654 | 82 | $2,458 |
| Jardiance Empagliflozin | 227 | 540 | 63 | $313K |
| Glimepiride Generic | 191 | 514 | 67 | $1,680 |
| Mounjaro Tirzepatide | 141 | 172 | 33 | $174K |
| Methimazole Generic | 141 | 317 | 39 | $1,297 |
| Farxiga Dapagliflozin Propanediol | 140 | 304 | 40 | $168K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 137 | 347 | 65 | $15K |
| Synthroid Levothyroxine Sodium | 108 | 251 | 28 | $8,767 |
| Tresiba Flextouch U-100 Insulin Degludec | 106 | 267 | 40 | $75K |
| Alendronate Sodium Generic | 100 | 269 | 31 | $800 |
| Novolog Flexpen Insulin Aspart | 99 | 182 | 37 | $27K |
| Januvia Sitagliptin Phosphate | 92 | 198 | 25 | $104K |
Brand drugs: 2,496 claims; generic drugs: 1,772 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kelly N Wood $951 ($951 in general payments such as food, travel and fees) from 19 companies. The largest payer was Amgen Inc. with $185.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 10 | $185 |
| Corcept Therapeutics CORT | 3 | $143 |
| Novo Nordisk Inc NVO | 5 | $106 |
| Xeris Pharmaceuticals, Inc. | 4 | $87.98 |
| Abbvie Inc. ABBV | 4 | $78.46 |
| Radius Health, Inc. | 2 | $48.12 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $30.89 |
| Globus Medical, Inc. GMED | 1 | $30.7 |
| Tandem Diabetes Care, Inc. TNDM | 1 | $29.36 |
| Mannkind Corporation MNKD | 1 | $28.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.